Search Results

In an effort to continue providing the highest quality of laboratory services and state-of-the art technologies to our customers, FlowMetric accepted the opportunity to collaborate directly with Cytek™Biosciences in providing feedback on the pre-designed panels associated with their next generation of flow cytometric instrumentation.

KCAS: Continuing to deliver against both growth objectives and more integrated customer service offerings, KCAS has acquired FlowMetric, LLC, a leading provider of flow cytometry and cellular assay R&D services to biotech, pharmaceutical and cell/gene therapy industries.

BurstIQ announced today that longtime partner FlowMetric Life Sciences, launched their novel vaccine immune response test, VaxEffect™.

FlowMetric Life Sciences Inc., a globally recognized life sciences company, announces the launch of VaxEffect™ COVID-19 Vaccine Immune Response Test, a unique and powerful platform exclusively created to quantitatively assess and track, now and over time, an individual’s immune response to any of the COVID-19 vaccines currently available in the United States.

FlowMetric Life Sciences, Inc. announced today that the state of Pennsylvania has certified the FlowMetric Diagnostics laboratory as a High Complexity laboratory under the Clinical Laboratory Improvement Amendments (CLIA) of 1988

FlowMetric Life Sciences, Inc., a global leader in immunology testing services, has launched a fleet of mobile COVID-19 testing labs capable of testing up to 300 individuals per day at any time and at any physical location.

FlowMetric Life Sciences announces that its Clinical Laboratory, which provides clinical immune-monitoring services, has been awarded accreditation by the College of American Pathologists (CAP) following an on-site inspection as part of the CAP’s Laboratory Improvement Program.

FlowMetric Diagnostics, Inc., a division of FlowMetric Life Sciences, Inc. focused on providing immune monitoring testing, announces the expansion of their testing services to include validated serological antibody testing for SARS-CoV-2 (COVID-19) exposure.

FlowMetric Life Sciences, Inc., is proud to announce that John M. Healey has joined the organization as the President of FlowMetric Diagnostics, Inc. and as the Executive Vice President of FlowMetric Life Sciences, Inc.

FlowMetric Life Sciences, Inc., a global leader in immunology testing services, and the Huck Institutes of the Life Sciences at Penn State University announce the creation of a long-term collaboration study assessing the impact on the Centre County community’s potential exposure to COVID-19 by Penn State University students returning to campus.